The global bioprocess bags market size reached US$ 2.93 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.6 Billion by 2028, exhibiting a growth rate (CAGR) of 17.10% during 2023-2028. The growing demand for biopharmaceuticals, increasing prevalence of chronic diseases, and rising outsourcing activities by various organizations represent some of the key factors driving the market.
Bioprocess bags are flexible and customizable solutions that are designed for the safe handling of liquids within the bioprocess environment. They are manufactured from a multilayer film that offers biocompatibility, chemical compatibility, and enhanced barrier and strength properties. They are widely available as single-use, cell culture, cryopreservation, single use beta, and spin bioprocess bags and in different sizes, designs, and shapes. They are highly reliable, cost-effective, and provide enhanced safety and hygiene among individuals. They are also temperature resistant and durable to withstand human and machine handling through specialized medical equipment. They assist in improving manufacturing productivity and minimizing the risk of cross-contamination as compared to traditional glass tubes and bottles. Besides this, they aid in decreasing cleaning time and reducing energy and water consumption. As a result, bioprocess bags are widely utilized for sampling, waste collection, separation, purification, and cold storage and transportation purposes across the globe.
Bioprocess Bags Market Trends:
At present, the rising demand for biopharmaceuticals, such as monoclonal antibodies and vaccines, represents one of the key factors supporting the growth of the market around the world. Besides this, the growing utilization of bioprocess bags due to the rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, among the masses is positively influencing the market. Additionally, the increasing adoption of bioprocess bags due to the outsourcing activity by contract manufacturing organizations (CMOs) and contract research organizations (CROs) worldwide is offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for single-use and disposable bioprocess bags across the globe. This, coupled with the increasing concern about maintaining safety and purity levels in human body samples, is propelling the growth of the market. In addition to this, technological advancements in bioprocessing procedures, such as single-use bioreactors, that increase efficiency and reduce the risk of cross-contamination are contributing to the growth of the market. Moreover, the growing adoption of bioprocess bags on account of the rising demand for personalized medicines is offering a favorable market outlook. Furthermore, the increasing demand for second-dimensional (2D) bioprocess bags, as they assist in streamlining the manufacturing process and reducing cost, is impelling the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global bioprocess bags market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, workflow, and end user.
- 2D Bioprocess Bags
- 3D Bioprocess Bags
- Other Bags and Accessories
The report has provided a detailed breakup and analysis of the bioprocess bags market based on the type. This includes 2D bioprocess bags, 3D bioprocess bags, and other bags and accessories. According to the report, 2D bioprocess bags represented the largest segment.
- Upstream Process
- Downstream Process
- Process Development
A detailed breakup and analysis of the bioprocess bags market based on the workflow has also been provided in the report. This includes upstream process, downstream process, process development, and others. According to the report, upstream process accounted for the largest market share.
End User Insights:
- Pharmaceutical and Biopharmaceutical Companies
- CMOs and CROs
- Academic and Research Institutes
A detailed breakup and analysis of the bioprocess bags market based on the end user has also been provided in the report. This includes pharmaceutical and biopharmaceutical companies, CMOs and CROs, academic and research institutes, and others. According to the report, pharmaceutical and biopharmaceutical companies accounted for the largest market share.
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for bioprocess bags. Some of the factors driving the North America bioprocess bags market included the growing incidences of chronic diseases, rising demand for personalized medicines, increasing employment in biopharmaceuticals, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global bioprocess bags market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include CellBios Healthcare & Lifesciences Pvt. Ltd., Charter Medical Ltd. (Solesis Medical Technologies Inc.), Compagnie de Saint-Gobain S.A., Danaher Corporation, Entegris Inc, FlexBiosys Inc. (Repligen Corporation), ILC Dover LP, Indutrade AB, PROAnalytics LLC, Sartorius AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- End User
||2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags and Accessories
||Upstream Process, Downstream Process, Process Development, Others
|End Users Covered
||Pharmaceutical and Biopharmaceutical Companies, CMOs and CROs, Academic and Research Institutes, Others
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||CellBios Healthcare & Lifesciences Pvt. Ltd., Charter Medical Ltd. (Solesis Medical Technologies Inc.), Compagnie de Saint-Gobain S.A., Danaher Corporation, Entegris Inc, FlexBiosys Inc. (Repligen Corporation), ILC Dover LP, Indutrade AB, PROAnalytics LLC, Sartorius AG, Thermo Fisher Scientific Inc., etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global bioprocess bags market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global bioprocess bags market?
- What is the impact of each driver, restraint, and opportunity on the global bioprocess bags market?
- What are the key regional markets?
- Which countries represent the most attractive bioprocess bags market?
- What is the breakup of the market based on the type?
- Which is the most attractive type in the bioprocess bags market?
- What is the breakup of the market based on the workflow?
- Which is the most attractive workflow in the bioprocess bags market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the bioprocess bags market?
- What is the competitive structure of the global bioprocess bags market?
- Who are the key players/companies in the global bioprocess bags market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the bioprocess bags market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global bioprocess bags market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the bioprocess bags industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.